|
Tapentadol-O-sulfate,
|
T-061
|
100 ug/mL (as free acid) in Methanol
A secondary urinary metabolite of tapentadol, the first new drug of the centrally-acting analgesic class approved in the US for pain management in more than 25 years. This new Certified Spiking Solution® is suitable for a variety of uses in LC/MS or GC/MS applications, such as pain prescription monitoring, forensic testing, clinical toxicology, or urine drug testing.
|
|
|